B
BioClarity
BioClarity is a three-step acne fighting treatment designed to give you a new kind of confidence—natural confidence
About BioClarity
BioClarity operates in the skincare industry, offering plant-based products designed to combat acne and improve overall skin health. The company targets consumers who are looking for effective, natural skincare solutions. BioClarity's business model revolves around direct-to-consumer sales through its website, where it offers a range of products including cleansers, masks, moisturizers, serums, and treatments. The company generates revenue by selling individual products as well as bundled routines. BioClarity differentiates itself with its use of Floralux, a proprietary form of chlorophyll, and other natural ingredients that are clinically proven to reduce acne and improve skin texture. The company also emphasizes its commitment to being vegan and cruelty-free, appealing to environmentally conscious consumers. BioClarity's market is primarily within the United States, as it currently does not ship internationally.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | May 2019 | $13M | $52M | Prolog Ventures | — |
| SEEDEquity / VC | Aug 2016 | $1.6M | $6.4M | Undisclosed | — |
Growth signals
Latest recorded traffic for BioClarity is 10K monthly website visits, up 0% over the last three months. BioClarity's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
BioClarity in the Fort Lee ecosystem
The BioClarity office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Prolog Ventures
Other known investors1 additional known investor
Agility Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BioClarity on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BioClarity’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







